Speedier drug approvals hit slowdown as FDA faces scrutiny

The Food and Drug Administration is slowing its use of a pathway that expedites the approval of promising drugs

Related Keywords

Washington ,United States ,Robert Califf ,Rick Pazdur ,Reshma Ramachandran ,Mike Sherman ,Sam Kay ,Yale University ,Drug Administration ,Congress Do ,Drug Approvals Pressure ,Legislation ,Corporate News ,Products And Services ,New Products And Services ,Product Approvals ,Drug Approvals ,Business ,Ealth Care Industry ,Harmaceutical Manufacturing ,Overnment Regulations ,Iseases And Conditions ,Dancer ,Legislature ,Overnment And Politics ,Health ,Iagnosis And Treatment ,Medication ,